325 related articles for article (PubMed ID: 24064469)
1. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study.
Benussi L; Rossi G; Glionna M; Tonoli E; Piccoli E; Fostinelli S; Paterlini A; Flocco R; Albani D; Pantieri R; Cereda C; Forloni G; Tagliavini F; Binetti G; Ghidoni R
J Alzheimers Dis; 2014; 38(4):799-808. PubMed ID: 24064469
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.
Galimberti D; Fenoglio C; Serpente M; Villa C; Bonsi R; Arighi A; Fumagalli GG; Del Bo R; Bruni AC; Anfossi M; Clodomiro A; Cupidi C; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Bessi V; Marcone A; Cerami C; Cappa SF; Filippi M; Agosta F; Magnani G; Comi G; Franceschi M; Rainero I; Giordana MT; Rubino E; Ferrero P; Rogaeva E; Xi Z; Confaloni A; Piscopo P; Bruno G; Talarico G; Cagnin A; Clerici F; Dell'Osso B; Comi GP; Altamura AC; Mariani C; Scarpini E
Biol Psychiatry; 2013 Sep; 74(5):384-91. PubMed ID: 23473366
[TBL] [Abstract][Full Text] [Related]
3. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
4. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
[TBL] [Abstract][Full Text] [Related]
5. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
6. The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration.
Erzurumluoglu E; Cilingir O; Ozbabalik Adapinar BD; Bilgic B; Kocagil S; Ozen H; Durak Aras B; Yenilmez C; Artan S
Neurobiol Aging; 2019 Apr; 76():216.e1-216.e7. PubMed ID: 30685122
[TBL] [Abstract][Full Text] [Related]
7. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
[TBL] [Abstract][Full Text] [Related]
8. C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia.
Galimberti D; Reif A; Dell'osso B; Kittel-Schneider S; Leonhard C; Herr A; Palazzo C; Villa C; Fenoglio C; Serpente M; Cioffi SM; Prunas C; Paoli RA; Altamura AC; Scarpini E
Neurobiol Aging; 2014 May; 35(5):1214.e7-1214.e10. PubMed ID: 24387986
[TBL] [Abstract][Full Text] [Related]
9. Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion.
Gómez-Tortosa E; Serrano S; de Toledo M; Pérez-Pérez J; Sainz MJ
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S284-9. PubMed ID: 24439166
[TBL] [Abstract][Full Text] [Related]
10. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.
Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ
Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645
[TBL] [Abstract][Full Text] [Related]
11. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases.
van Rheenen W; van Blitterswijk M; Huisman MH; Vlam L; van Doormaal PT; Seelen M; Medic J; Dooijes D; de Visser M; van der Kooi AJ; Raaphorst J; Schelhaas HJ; van der Pol WL; Veldink JH; van den Berg LH
Neurology; 2012 Aug; 79(9):878-82. PubMed ID: 22843265
[TBL] [Abstract][Full Text] [Related]
12. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan.
Tsai CP; Soong BW; Tu PH; Lin KP; Fuh JL; Tsai PC; Lu YC; Lee IH; Lee YC
Neurobiol Aging; 2012 Sep; 33(9):2232.e11-2232.e18. PubMed ID: 22673113
[TBL] [Abstract][Full Text] [Related]
13. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C
Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.
Mahoney CJ; Beck J; Rohrer JD; Lashley T; Mok K; Shakespeare T; Yeatman T; Warrington EK; Schott JM; Fox NC; Rossor MN; Hardy J; Collinge J; Revesz T; Mead S; Warren JD
Brain; 2012 Mar; 135(Pt 3):736-50. PubMed ID: 22366791
[TBL] [Abstract][Full Text] [Related]
15. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
16. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.
Davidson YS; Barker H; Robinson AC; Thompson JC; Harris J; Troakes C; Smith B; Al-Saraj S; Shaw C; Rollinson S; Masuda-Suzukake M; Hasegawa M; Pickering-Brown S; Snowden JS; Mann DM
Acta Neuropathol Commun; 2014 Jun; 2():70. PubMed ID: 24950788
[TBL] [Abstract][Full Text] [Related]
17. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.
Cooper-Knock J; Shaw PJ; Kirby J
Acta Neuropathol; 2014 Mar; 127(3):333-45. PubMed ID: 24493408
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
[TBL] [Abstract][Full Text] [Related]
19. The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues.
Woollacott IO; Mead S
Acta Neuropathol; 2014 Mar; 127(3):319-32. PubMed ID: 24515836
[TBL] [Abstract][Full Text] [Related]
20. C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Fenoglio C; De Riz M; Villa C; Serpente M; Ridolfi E; Bonsi R; Cioffi SM; Barone C; Pietroboni A; Calvi A; Scarpini E; Galimberti D
Neurobiol Aging; 2014 May; 35(5):1213.e1-2. PubMed ID: 24355526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
